ES2816061T3 - Ensayo y lector de contraste térmico - Google Patents
Ensayo y lector de contraste térmico Download PDFInfo
- Publication number
- ES2816061T3 ES2816061T3 ES17204410T ES17204410T ES2816061T3 ES 2816061 T3 ES2816061 T3 ES 2816061T3 ES 17204410 T ES17204410 T ES 17204410T ES 17204410 T ES17204410 T ES 17204410T ES 2816061 T3 ES2816061 T3 ES 2816061T3
- Authority
- ES
- Spain
- Prior art keywords
- test
- analyte
- sample
- nanoparticles
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000003556 assay Methods 0.000 title claims abstract description 69
- 238000012360 testing method Methods 0.000 claims abstract description 139
- 239000002105 nanoparticle Substances 0.000 claims abstract description 132
- 239000012491 analyte Substances 0.000 claims abstract description 88
- 238000000034 method Methods 0.000 claims abstract description 47
- 230000004044 response Effects 0.000 claims abstract description 28
- 230000009471 action Effects 0.000 claims abstract description 17
- 239000000427 antigen Substances 0.000 claims description 41
- 108091007433 antigens Proteins 0.000 claims description 41
- 102000036639 antigens Human genes 0.000 claims description 41
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 27
- 229910052737 gold Inorganic materials 0.000 claims description 24
- 239000010931 gold Substances 0.000 claims description 24
- 201000004792 malaria Diseases 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 10
- 239000002077 nanosphere Substances 0.000 claims description 9
- 239000002250 absorbent Substances 0.000 claims description 6
- 230000002745 absorbent Effects 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 241000223960 Plasmodium falciparum Species 0.000 claims description 2
- 206010037660 Pyrexia Diseases 0.000 claims description 2
- 229910021389 graphene Inorganic materials 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 56
- 238000001514 detection method Methods 0.000 description 41
- 239000012528 membrane Substances 0.000 description 35
- 238000010521 absorption reaction Methods 0.000 description 26
- 230000035945 sensitivity Effects 0.000 description 24
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 21
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 21
- 230000008859 change Effects 0.000 description 20
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 20
- 239000000463 material Substances 0.000 description 17
- 230000000007 visual effect Effects 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 9
- 238000011002 quantification Methods 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000009825 accumulation Methods 0.000 description 6
- 230000020169 heat generation Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 239000002078 nanoshell Substances 0.000 description 5
- 208000006081 Cryptococcal meningitis Diseases 0.000 description 4
- 206010027209 Meningitis cryptococcal Diseases 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 208000030507 AIDS Diseases 0.000 description 3
- 201000007336 Cryptococcosis Diseases 0.000 description 3
- 241000221204 Cryptococcus neoformans Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 201000009906 Meningitis Diseases 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000012125 lateral flow test Methods 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 2
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 2
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000000424 optical density measurement Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000009597 pregnancy test Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012124 rapid diagnostic test Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000004639 AIDS-Related Opportunistic Infections Diseases 0.000 description 1
- 101710145634 Antigen 1 Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000009362 Pneumococcal Pneumonia Diseases 0.000 description 1
- 206010035728 Pneumonia pneumococcal Diseases 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 244000176261 Viburnum cassinoides Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 238000001636 atomic emission spectroscopy Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108091005996 glycated proteins Proteins 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000031070 response to heat Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 208000022218 streptococcal pneumonia Diseases 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4806—Details not adapted to a particular type of sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
- G01N2021/8488—Investigating reagent band the band presenting reference patches
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Combustion & Propulsion (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analyzing Materials Using Thermal Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Radiation Pyrometers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261593036P | 2012-01-31 | 2012-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2816061T3 true ES2816061T3 (es) | 2021-03-31 |
Family
ID=47754956
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13706780.7T Active ES2661870T3 (es) | 2012-01-31 | 2013-01-30 | Ensayo y lector de contraste térmico |
| ES17204410T Active ES2816061T3 (es) | 2012-01-31 | 2013-01-30 | Ensayo y lector de contraste térmico |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13706780.7T Active ES2661870T3 (es) | 2012-01-31 | 2013-01-30 | Ensayo y lector de contraste térmico |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9651508B2 (enExample) |
| EP (2) | EP3321666B1 (enExample) |
| JP (1) | JP2015509201A (enExample) |
| KR (1) | KR20140127275A (enExample) |
| CN (2) | CN107505465B (enExample) |
| AP (1) | AP2014007834A0 (enExample) |
| BR (1) | BR112014018563A2 (enExample) |
| ES (2) | ES2661870T3 (enExample) |
| IN (1) | IN2014MN01698A (enExample) |
| PL (1) | PL2810052T3 (enExample) |
| WO (1) | WO2013116333A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150010441A1 (en) * | 2013-07-02 | 2015-01-08 | Elana M. Kahn | Electronic Pregnancy Test Device |
| US10001449B2 (en) | 2014-12-15 | 2018-06-19 | Church & Dwight Co., Inc. | Systems, devices and methods for a hydroscopic based lateral flow assay |
| US20160169887A1 (en) * | 2014-12-15 | 2016-06-16 | Church & Dwight, Co., Inc. | Systems, devices and methods for a lateral flow assay with solution enhancement |
| US10094823B2 (en) * | 2015-01-23 | 2018-10-09 | Tokitae Llc | Photothermal spectroscopy assay readers, and related assay kits and methods |
| US9625385B2 (en) * | 2015-02-24 | 2017-04-18 | Tokitae Llc | Photothermal spectroscopy systems for offset synchronous testing of flow assays and methods of using same |
| CN105242047B (zh) * | 2015-10-31 | 2017-05-31 | 中国农业科学院油料作物研究所 | 黄曲霉毒素b1氧化石墨烯免疫层析试纸条及其应用 |
| CN105259094B (zh) * | 2015-11-20 | 2018-11-09 | 厦门大学 | 基于红外热像的免疫层析试条样品液流速检测系统与方法 |
| US10132743B2 (en) * | 2016-01-25 | 2018-11-20 | General Electric Company | Fixed optics photo-thermal spectroscopy reader and method of use |
| US10983119B2 (en) | 2016-01-25 | 2021-04-20 | General Electric Company | Device for rapid diagnostic tests to detect antigens with improved sensitivity |
| EP3541506A4 (en) * | 2016-11-17 | 2020-09-23 | Celsee Diagnostics, Inc. | SYSTEM AND METHOD FOR RECOVERING AND ANALYZING PARTICLES |
| KR101996815B1 (ko) * | 2017-07-07 | 2019-07-05 | 한국과학기술연구원 | 적외선을 흡광 및 발광하는 진단용 포획제-나노입자 복합체 및 이를 이용하는 현장용 진단키트 |
| EP4092467A1 (en) * | 2017-09-29 | 2022-11-23 | Leica Biosystems Imaging, Inc. | Two-dimensional and three-dimensional fixed z scanning |
| CA3276112A1 (en) | 2017-11-04 | 2025-10-30 | Sona Nanotech Inc. | Metal nanoparticles and methods of making same |
| US10228321B1 (en) * | 2017-11-21 | 2019-03-12 | Saudi Arabian Oil Company | System and method for infrared reflection avoidance |
| CA2986532C (en) * | 2017-11-23 | 2022-06-28 | Pouya Rezai | System and method for photo-thermal analysis of immunoassay tests |
| US10837962B2 (en) | 2017-12-20 | 2020-11-17 | General Electric Company | Method and associated device for rapid detection of target biomolecules with enhanced sensitivity |
| US10830760B2 (en) | 2017-12-20 | 2020-11-10 | General Electric Company | Device for rapid detection of tuberculosis-lipoarabinomannan (TB-LAM) with enhanced sensitivity |
| CN108375678A (zh) * | 2018-02-09 | 2018-08-07 | 上海格荣生物科技有限公司 | 检测前列腺肿瘤抗原的试纸条及方法 |
| CN108680508A (zh) * | 2018-05-18 | 2018-10-19 | 中国检验检疫科学研究院 | 一体式光热效应检测仪 |
| EP3811057A4 (en) * | 2018-06-22 | 2022-02-23 | Oova, Inc. | ANALYTE LEVEL DETECTION METHODS, DEVICES AND SYSTEMS |
| JP7130045B2 (ja) * | 2018-08-31 | 2022-09-02 | 富士フイルム株式会社 | イムノクロマトグラフキットおよび結核菌の検出方法 |
| EP4136449A1 (de) * | 2020-04-16 | 2023-02-22 | Senova Gesellschaft für Biowissenschaft und Technik mbH | Lateral flow assay |
| WO2021231659A1 (en) * | 2020-05-12 | 2021-11-18 | Sapphire Biotech, Inc. | Neutralizing antibody testing and treatment |
| US20220205998A1 (en) * | 2020-05-12 | 2022-06-30 | Sapphire Biotech, Inc. | Assay for neutralizing antibody testing and treatment |
| US20220244258A1 (en) * | 2020-05-12 | 2022-08-04 | Sapphire Biotech, Inc. | Assay For Neutralizing Antibody Testing And Treatment |
| US12453805B2 (en) | 2020-09-24 | 2025-10-28 | Everest Medical Innovation GmbH | Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery |
| US12426594B2 (en) | 2020-09-24 | 2025-09-30 | Everest Medical Innovation GmbH | Cryoprotective compositions and methods for protection of a surgical site during cryosurgery |
| CN114280047B (zh) * | 2021-12-28 | 2024-01-05 | 江南大学 | 一种检测小分子化合物的比色-光热双模式试纸条及其制备方法 |
| CN119555612B (zh) * | 2025-01-22 | 2025-05-13 | 北京航空航天大学 | 基于rgb和热红外技术的光热传感装置及抗光漂白检测方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4094647A (en) | 1976-07-02 | 1978-06-13 | Thyroid Diagnostics, Inc. | Test device |
| NL7807532A (nl) | 1978-07-13 | 1980-01-15 | Akzo Nv | Metaal-immunotest. |
| US5073484A (en) | 1982-03-09 | 1991-12-17 | Bio-Metric Systems, Inc. | Quantitative analysis apparatus and method |
| IT1160788B (it) | 1983-04-15 | 1987-03-11 | Belleli Spa | Supporto di fascio tubiero in scambiatori di calore |
| US5514602A (en) | 1986-06-09 | 1996-05-07 | Ortho Diagnostic Systems, Inc. | Method of producing a metal sol reagent containing colloidal metal particles |
| CA1303983C (en) | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
| US4857453A (en) | 1987-04-07 | 1989-08-15 | Syntex (U.S.A.) Inc. | Immunoassay device |
| EP0560410B1 (en) | 1987-04-27 | 2002-10-02 | Inverness Medical Switzerland GmbH | A test device for performing specific binding assays |
| US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
| AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
| US6352862B1 (en) | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
| US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
| US6136610A (en) * | 1998-11-23 | 2000-10-24 | Praxsys Biosystems, Inc. | Method and apparatus for performing a lateral flow assay |
| CA2366802A1 (en) * | 2001-01-17 | 2002-07-17 | Bayer Corporation | Method and apparatus for using infrared readings to detect misidentification of a diagnostic test strip in a reflectance spectrometer |
| DK1432786T3 (da) | 2001-09-06 | 2009-10-26 | Rapid Micro Biosystems Inc | Hurtig detektion af replikerede celler |
| US8367013B2 (en) | 2001-12-24 | 2013-02-05 | Kimberly-Clark Worldwide, Inc. | Reading device, method, and system for conducting lateral flow assays |
| EP1459099A4 (en) * | 2001-12-27 | 2006-08-23 | Inverness Medical Switzerland | NOVEL COMPONENT, SYSTEM AND METHOD FOR FLUORESCENT DETECTION |
| WO2003062824A1 (en) | 2002-01-23 | 2003-07-31 | Boditech Inc. | Lateral flow quantitative assay method and strip and laser-induced fluoerescence detection device therefor |
| US7314763B2 (en) | 2002-08-27 | 2008-01-01 | Kimberly-Clark Worldwide, Inc. | Fluidics-based assay devices |
| US20040180369A1 (en) * | 2003-01-16 | 2004-09-16 | North Carolina State University | Photothermal detection of nucleic acid hybridization |
| US20040197819A1 (en) | 2003-04-03 | 2004-10-07 | Kimberly-Clark Worldwide, Inc. | Assay devices that utilize hollow particles |
| WO2004092715A1 (en) * | 2003-04-15 | 2004-10-28 | Optiscan Biomedical Corporation | Sample element for use in material analysis |
| KR100639776B1 (ko) | 2004-01-05 | 2006-10-27 | 바이오메드포토닉스 주식회사 | 측방 유동 정량 검정 방법 및 이를 위한 스트립과 레이저유발 표면형광 검출 장치 및 소형 스캐너 |
| US20080032420A1 (en) * | 2004-03-30 | 2008-02-07 | Lambert James L | Surface Enhanced Raman Scattering and Multiplexed Diagnostic Assays |
| US8128871B2 (en) | 2005-04-22 | 2012-03-06 | Alverix, Inc. | Lateral flow assay systems and methods |
| US8153444B2 (en) | 2005-10-13 | 2012-04-10 | Auric Enterprises, Llc | Immuno gold lateral flow assay |
| EP1977242B1 (en) | 2006-01-27 | 2016-08-03 | Becton Dickinson and Company | Lateral flow immunoassay with encapsulated detection modality |
| CN101449145A (zh) | 2006-05-24 | 2009-06-03 | 皇家飞利浦电子股份有限公司 | 用于对对象进行温度和发光组合空间成像的成像设备 |
| WO2008067079A2 (en) | 2006-10-20 | 2008-06-05 | Cardiospectra, Inc. | Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles |
| US8108030B2 (en) * | 2006-10-20 | 2012-01-31 | Board Of Regents, The University Of Texas System | Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles |
| US20080102473A1 (en) | 2006-10-31 | 2008-05-01 | Fouquet Julie E | Method and system to improve contrast in lateral flow assay |
| EP1933147B1 (en) | 2006-12-11 | 2011-08-17 | AraGen Biotechnology Co. Ltd. | Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| WO2009152209A2 (en) | 2008-06-10 | 2009-12-17 | Rapid Pathogen Screening, Inc. | Combined visual/fluorescence analyte detection test |
| CN101368907A (zh) * | 2008-07-14 | 2009-02-18 | 马义才 | 一种基于cmos图像传感器的量子点标记试条定量检测系统 |
| WO2010065781A2 (en) | 2008-12-03 | 2010-06-10 | Abaxis, Inc. | Lateral flow strip assay with immobilized conjugate |
| CN102782495B (zh) | 2009-11-04 | 2014-12-31 | 托马斯·M·布坎南 | 用于在快速侧流免疫测定中增强灵敏度以及评估样品充足性和试剂反应性的方法和装置 |
| US20130184184A1 (en) | 2010-11-22 | 2013-07-18 | The University Of Chicago | Methods and/or Use of Oligonucleotide Conjugates Having Varied Degrees of Labeling for Assays and Detections |
-
2013
- 2013-01-30 IN IN1698MUN2014 patent/IN2014MN01698A/en unknown
- 2013-01-30 BR BR112014018563A patent/BR112014018563A2/pt not_active IP Right Cessation
- 2013-01-30 CN CN201710664648.2A patent/CN107505465B/zh active Active
- 2013-01-30 PL PL13706780T patent/PL2810052T3/pl unknown
- 2013-01-30 EP EP17204410.9A patent/EP3321666B1/en active Active
- 2013-01-30 US US14/375,294 patent/US9651508B2/en active Active
- 2013-01-30 CN CN201380016094.5A patent/CN104471382B/zh active Active
- 2013-01-30 WO PCT/US2013/023839 patent/WO2013116333A2/en not_active Ceased
- 2013-01-30 ES ES13706780.7T patent/ES2661870T3/es active Active
- 2013-01-30 EP EP13706780.7A patent/EP2810052B1/en active Active
- 2013-01-30 KR KR1020147023705A patent/KR20140127275A/ko not_active Ceased
- 2013-01-30 ES ES17204410T patent/ES2816061T3/es active Active
- 2013-01-30 AP AP2014007834A patent/AP2014007834A0/xx unknown
- 2013-01-30 JP JP2014555670A patent/JP2015509201A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013116333A3 (en) | 2013-11-07 |
| JP2015509201A (ja) | 2015-03-26 |
| BR112014018563A2 (pt) | 2017-08-22 |
| EP2810052A2 (en) | 2014-12-10 |
| EP3321666B1 (en) | 2020-06-17 |
| CN107505465A (zh) | 2017-12-22 |
| US20140377770A1 (en) | 2014-12-25 |
| EP2810052B1 (en) | 2017-12-06 |
| WO2013116333A2 (en) | 2013-08-08 |
| IN2014MN01698A (enExample) | 2015-05-29 |
| AP2014007834A0 (en) | 2014-07-31 |
| CN107505465B (zh) | 2020-01-14 |
| CN104471382A (zh) | 2015-03-25 |
| EP3321666A1 (en) | 2018-05-16 |
| ES2661870T3 (es) | 2018-04-04 |
| US9651508B2 (en) | 2017-05-16 |
| PL2810052T3 (pl) | 2018-07-31 |
| KR20140127275A (ko) | 2014-11-03 |
| CN104471382B (zh) | 2017-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2816061T3 (es) | Ensayo y lector de contraste térmico | |
| US10816492B2 (en) | Lateral flow assays with thermal contrast readers | |
| Ye et al. | Signal amplification and quantification on lateral flow assays by laser excitation of plasmonic nanomaterials | |
| US10871486B2 (en) | Device and method for performing a diagnostic test | |
| JP6034466B2 (ja) | ポイントオブケア・テストの結果を読み取るためのハンドヘルド・スキャナ・システム及び方法 | |
| US10725033B2 (en) | Lateral flow assays with thermal contrast readers | |
| ES2938645T3 (es) | Ensayos de tipo sándwich que utilizan partes de señal decreciente de la curva de respuesta de dosis para medir analitos, incluyendo analitos a concentración elevada | |
| JP5554289B2 (ja) | イムノクロマトグラフィー用検出装置及びその検出方法 | |
| US20180275058A1 (en) | Systems and methods for multiplexed detection of biomarkers | |
| JP5583092B2 (ja) | イムノクロマトグラフィー用試験キット、これを用いた検出方法 | |
| ES2700602T3 (es) | Una pieza de prueba inmunocromatográfica | |
| Russo et al. | Detection of resistance protein A (MxA) in paper-based immunoassays with surface enhanced Raman spectroscopy with AuAg nanoshells | |
| Khan et al. | A facile plasmonic silver needle for fluorescence-enhanced detection of tumor markers | |
| US11320425B2 (en) | Enhanced infrared ray absorbing/emitting nanoparticles and on-site diagnosis kit using same | |
| TWI645186B (zh) | 用於生物檢測之阻抗晶片檢測系統 | |
| OA17012A (en) | Thermal contrast assay and reader | |
| ES2953527T3 (es) | Optimización de un biosensor de evanescencia | |
| JP2011214858A (ja) | クロマトグラフ測定方法、並びにそれに用いる不溶性担体および測定装置 | |
| CN113933518A (zh) | C蛋白检测试纸的制备方法及掌上式读取装置 | |
| Monroe | Highly sensitive and multiplexed platforms for allergy diagnostics | |
| WO2013156820A1 (en) | Simultaneous multiple wavelength fluorescence measurement device, methods therefor and system therefrom |